SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-014297
Filing Date
2022-07-21
Accepted
2022-07-21 16:09:25
Documents
1
Period of Report
2022-07-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 5303
  Complete submission text file 0001567619-22-014297.txt   6667
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913
Business Address
HANNAH ALISON L. (Reporting) CIK: 0001645600 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37587 | Film No.: 221097158